Geriatric Assessment in patients older than 60 years with hematological malignancies undergoing allogeneic stem cell transplantatio

• Conditions: C92.0; D46; Acute myeloblastic leukaemia [AML]; Myelodysplastic syndromes

• Registration Number: DRKS00003694
• Lead Sponsor: Hämatologie, Onkologie Med I

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-04-30
• Study Completion: 2015-09-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 117

Inclusion Criteria

written informed consent, higher risk MDS, AML, anticipated allogeneic stem cell transplantation, mental capacity top fill out questionnaires and obey simple orders. Regional proxicity for regular follow-up

Exclusion Criteria

other malignancies not in remission, inability to fill out german questionnaires, lack of informed consent. Trial participation in a medical treatment study is NOT an exclusion criterion.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Progression free survival (PFS). <br>Hazard ratios for PFS will be calculated

Secondary Outcome Measures

Name	Time	Method
Overall survival